Kristina Maximenko

Ufficiale delle Risorse Umane presso DIANTHUS THERAPEUTICS, INC.

Health Technology

Finance

Consumer Services

Profilo

Kristina Maximenko currently works at Dianthus Therapeutics, Inc., as Chief People Officer from 2023.
Ms. Maximenko also formerly worked at Advanced Accelerator Applications SA, as Director-Human Resources, Abeona Therapeutics, Inc., as Vice-President & Head-Human Resources, and Fast Group, as Global Human Resource Manager.
Ms. Maximenko received her graduate degree from Far Eastern University.

Posizioni attive di Kristina Maximenko

Società	Posizione	Inizio
DIANTHUS THERAPEUTICS, INC.	Ufficiale delle Risorse Umane	11/09/2023

Tutte le posizioni attive di Kristina Maximenko

Precedenti posizioni note di Kristina Maximenko

Società	Posizione	Fine
ADVANCED ACCELERATOR APPLICATION SA(ADR)	Ufficiale delle Risorse Umane	-
Fast Group Fast Group Finance/Rental/LeasingFinance Fast Group provides mortgage and financial services. The Australian company was founded by Garry Benjamin Ralston.	Ufficiale delle Risorse Umane	-
ABEONA THERAPEUTICS INC.	Ufficiale delle Risorse Umane	-

Vedi nel dettaglio l'esperienza di Kristina Maximenko

Formazione di Kristina Maximenko

Far Eastern University

Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Kristina Maximenko

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
ABEONA THERAPEUTICS INC.	Health Technology
DIANTHUS THERAPEUTICS, INC.	Health Technology

Aziende private	2
Fast Group Fast Group Finance/Rental/LeasingFinance Fast Group provides mortgage and financial services. The Australian company was founded by Garry Benjamin Ralston.	Finance
Advanced Accelerator Applications SA Advanced Accelerator Applications SA Medical SpecialtiesHealth Technology Advanced Accelerator Applications SA is a radiopharmaceutical company, which develops, produces and commercializes molecular nuclear medicine products. The firm offers research and development in medicinal and pharmaceutical therapeutic products mainly focusing in cardiology and neurology. It manufactures both diagnostic and therapeutic MNM products for commercialization. The company was founded by Stefano Buono in 2002 and is headquartered in Rueil-Malmaison Cedex, France.	Health Technology